These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20716219)

  • 1. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Br J Dermatol; 2010 Dec; 163(6):1282-90. PubMed ID: 20716219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis.
    Rácz E; de Leeuw J; Baerveldt EM; Kant M; Neumann HA; van der Fits L; Prens EP
    Lasers Surg Med; 2010 Mar; 42(3):201-10. PubMed ID: 20333742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrowband ultraviolet B versus psoralen plus ultraviolet A therapy for severe plaque psoriasis: an Indian perspective.
    Chauhan PS; Kaur I; Dogra S; De D; Kanwar AJ
    Clin Exp Dermatol; 2011 Mar; 36(2):169-73. PubMed ID: 20545955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
    Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
    Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin.
    Premkumar VG; Yuvaraj S; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Basic Clin Pharmacol Toxicol; 2007 Jun; 100(6):387-91. PubMed ID: 17516992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of immune suppression of systemic inflammation by the action of the narrowband ultraviolet B (311 nm) therapy in patients with psoriasis].
    Babanin VA
    Lik Sprava; 2013; (3):97-102. PubMed ID: 25016757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris.
    Anderson KS; Petersson S; Wong J; Shubbar E; Lokko NN; Carlström M; Enerbäck C
    Br J Dermatol; 2010 Nov; 163(5):1085-9. PubMed ID: 20716221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
    Serwin AB; Wasowicz W; Chodynicka B
    Nutrition; 2006 Sep; 22(9):860-4. PubMed ID: 16829029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoralen plus ultraviolet A light phototherapy effectiveness.
    Feldman SR
    J Am Acad Dermatol; 2010 Oct; 63(4):718. PubMed ID: 20846573
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
    J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB.
    Akman A; Dicle O; Yilmaz F; Coskun M; Yilmaz E
    Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):123-7. PubMed ID: 18477130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narrowband ultraviolet B phototherapy does not influence serum and red cell folate levels in patients with psoriasis.
    Rose RF; Batchelor RJ; Turner D; Goulden V
    J Am Acad Dermatol; 2009 Aug; 61(2):259-62. PubMed ID: 19493587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.
    Arican O; Aral M; Sasmaz S; Ciragil P
    Mediators Inflamm; 2005 Oct; 2005(5):273-9. PubMed ID: 16258194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis.
    Shimauchi T; Hirakawa S; Suzuki T; Yasuma A; Majima Y; Tatsuno K; Yagi H; Ito T; Tokura Y
    J Dermatol; 2013 Oct; 40(10):805-12. PubMed ID: 23915382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
    Jacob SE; Nassiri M; Kerdel FA; Vincek V
    Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum.
    Murakami M; Hagforsen E; Morhenn V; Ishida-Yamamoto A; Iizuka H
    Exp Dermatol; 2011 Oct; 20(10):845-7. PubMed ID: 21732985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis.
    Ryan C; Renfro L; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2010 Nov; 163(5):1056-63. PubMed ID: 20716226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers -- IL-12, IL-18 and IL-23.
    Piskin G; Tursen U; Sylva-Steenland RM; Bos JD; Teunissen MB
    Exp Dermatol; 2004 Dec; 13(12):764-72. PubMed ID: 15560760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
    Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.